NAP 226-90 is a metabolite of rivastigmine that is formed by hydrolysis.1
1.Polinsky, R.J.Clinical pharmacology of rivastigmine: A new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's diseaseClin. Ther.20(4)634-647(1998)
NAP 226-90 is a metabolite of rivastigmine that is formed by hydrolysis.1
1.Polinsky, R.J.Clinical pharmacology of rivastigmine: A new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's diseaseClin. Ther.20(4)634-647(1998)